It is well established that the prohormone of p-endorphin and ACTH undergoes tissue-specific processing in that the nature and amounts of its fragments differ in different tissues (Smyth et al., 1981) . In the anterior pituitary the principal biologically active peptides are ACTH and pendorphin, whereas in the pars intermedia the active peptides are a-melanotropin and p-endorphin (Zakarian & Smyth, 1982a; Jackson & Lowry, 1980) . Different patterns of peptides have also been observed in regions of brain (Smyth & Zakarian, 1982) . The extent to which pendorphin is present as the biologically potent peptide depends on the degree of its processing to form the shorter peptides, p-endorphin 1-27 and p-endorphin 1-26, and whether these peptides are a, N-acetylated (Fig. 1) . Thus pendorphin is inactivated both by N-acetylation and Cterminal proteolysis (Deakin et al., 1980) and the degree of its inactivation differs in different tissues.
Recent experiments have shown that the degree of processing of the P-endorphin prohormone in a specific tissue can vary. In rat anterior pituitary, significant changes . We report here that the processing of p-endorphin in rat pars intermedia is affected by chronic treatment with haloperidol, a dopamine antagonist, and furthermore that the processing of p-endorphin in pars intermedia cells grown in monolayer culture is sensitive to the presence of apomorphine.
Groups of five male Sprague-Dawley rats (200-25Og) received ha:operidol(l mg/kg intraperitoneally) daily while control rats were administered with saline in the same regimen. After 10 days, the rats were killed by injection of sodium pentobarbital (1 20mg), the pituitary was removed and the pars intermedia plus pars nervosa separated from the pars distalis. The endogenous peptides were extracted from the pars intermedia by homogenization in acid acetone and after purification by gel filtration on Sephadex G75 in 50% acetic acid, the six p-endorphin-related peptides were resolved by ion-exchange chromatography on the pyridinium form of SP Sephadex C25 in 50% acetic acid with a pyridine gradient (Zakarian & Smyth, 19826) . The peptides in the eluted fractions were identified by correlation with 251-labelled reference peptides and were determined by radioimmunoassay with a p-endorphin antiserum (Zakarian & Smyth, 1979) .
The results showed that the pars intermedia of the haloperidol-treated rats contained considerably more 'immunoreactive p-endorphin' (70-100% above control) than b-Endorphin-related peptides were extracted and resolved by ion-exchange chromatography (see text). The eluted fractions were immunoassayed with a &endorphin antiserum. The arrows (left to right) indicate the elution positions of radiolabelled reference peptides: a, N-acetyl @-endorphin 1-27; B-endorphin 1-27; cl,N-acetyl j-endorphin 1-31 ; fi-endorphin 1-31. Peaks 1 and 3 (not indicated by marker peptides) correspond to a, N-acetyl P-endorphin 1-26 and B-endorphin 1-26 respectively. the pars intermedia of the control rats, in agreement with the results of Hollt & Bergmann (1982) . The increase, however, was found to be accounted for by higher levels of the acetylated forms of B-endorphin 1-26, B-endorphin 1-27 and 8-endorphin 1-31; little change was seen in the unmodified NH2 forms of these peptides. Thus the effect of the haloperidol treatment was that C-terminal proteolysis and N-terminal acetylation were accentuated, leading to inactivation of fl-endorphin. Treatment of rats with haloperidol has previously been shown to lead to increased biosynthesis of the ACTH j?-endorphin prohormone and it also leads to increased secretion (Giraud et al., 1980) . The present results demonstrate that haloperido1 can modify the intracellular processing of p-endorphin and hence influence the extent to which it is inactivated.
To obtain more direct information on the effect of dopaminergic agents on /3-endorphin processing, rat pars intermedia cells which lack dopaminergic innervation were grown in monolayer culture (Kirkland & Ellison, 1981) and the effects of apomorphine were examined on the processing patterns. The cells were allowed to grow in 90% (v/v) Dulbecco's Eagles medium (Hepes-buffered), 10% foetal calf serum, for 7 days with replenishment of the culture medium at 48 h intervals. Control cells were seen to exhibit the processing pattern shown in Fig. 2 . In contrast, cells treated with apomorphine (5 x for 2 h showed a significant departure from the control pattern: both proteolysis and N-acetylation were markedly increased (Fig. 2) . The resulting pattern of /.I-endorphin-related peptides in the apomorphine-treated rats resembled the pattern that is characteristic of the pars intermedia in situ.
These findings suggest that the processing of the pendorphin prohormone in pars intermedia cells may be influenced by the rate of secretion of the processed peptides since exposure of the cultured cells to a dopatninergic agent, which inhibits secretion, restored the processing pattern to that of the pars intermedia in vivo.
The changes in the processing of fi-endorphin-related peptides observed in these experiments raises the possibility that similar changes may be induced by physiological as well as pharmacological stimuli.
The significance of /%endorphin regulation in the pituitary has been clarified by recent studies indicating a peripheral receptor to /l-endorphin. Using a new radiolabelled derivative, [3-iodo-TyrZ7]/.?-endorphin 1-31, administered intravenously it was shown that p-endorphin concentrates with a high degree of specificity in the gastric antrum and duodenum. This indicates that &endorphin released from the pituitary gland may fulfil a role in controlling digestion in the gastro-intestinal tract. Thus the processing of &endorphin in the pituitary may have a special physiological relevance in conjunction with ACTH , P-endorphin acting on the antrum and small intestine and ACTH acting on the adrenal gland. The present results suggest that a mechanism exists which allows differential regulation of the two bioactivities. Disulphide bonds are found in practically every class of extracellular protein, and the formation of disulphide bonds must be regarded as a key post-translational modification of secretory proteins. Despite this, and despite the fact that the existence of disulphide bonds has been known for many years, the mechanism of disulphide bond formation during protein biosynthesis and secretion is not well established, especially by comparison with more recently discovered modifications also discussed in this Colloquium, such as proteolysis of signal sequences or y-carboxylation of glutamyl residues. This is because the problem lies on the periphery of three distinct fields : (i) post-translational modification, (ii) protein biosynthesis, translocation and processing, and (iii) protein folding.
Most work on the formation of protein disulphide bonds has derived from an interest in the chemistry of protein folding and so has involved model studies, rather than studies aimed at characterizing the process as it occurs in the cell. However, this line of work has been remarkably informative. The classic work of Anfinsen and his colleagues established that small, single-domain disulphidebonded proteins, such as ribonuclease, after reduction in denaturing conditions, would recover in high yield their native disulphide-bond pairing, conformation and activity on removal of the denaturant and reductant. (Epstein et al., 1963; Anfinsen, 1972) . This result established that the native tertiary structure is defined by the amino acid sequence and that the disulphide bonds do not carry structural information. However, it does not imply that disulphide bond formation is irrelevant to the process of protein folding or the maintenance of the native state. Both insulin and collagen cannot be directly folded to their native state. Both are in a metastable state in a conformation achieved by folding of a disulphide-bonded precursor (Freedman & Hawkins, 1977) . Thus in both cases appropriate disulphide bond formation is essential either to generate, or to maintain, the biologically active conformation.
Recent work has thrown more light on the mechanism of disulphide bond formation in model studies in vitro. Firstly, the use of disulphide oxidants (rather than the dissolved O2 used in Anfinsen's studies) has clarified the chemistry of the process and established that protein disulphide bond formation occurs via a series of thiol :disulphide interchange reactions (Wetlaufer & Ristow, 1973) . Secondly, the isolation by Creighton of specific disulphide-bonded intermediates of the folding and oxidation process has permitted a full kinetic and thermodynamic description of the pathway, in the case of bovine pancreatic trypsin inhibitor, a small protein containing three disulphide bonds. (Creighton, 1978) . This work has established that there is a kinetically favoured folding route, but that the native disulphide bonds are not simply introduced in turn; species Present address: Inorganic Chemistry Laboratory, University of Oxford, South Parks Road, Oxford 0x1 3QU, U.K.
with non-native bonds are obligatory intermediates. Thus the rate of protein disulphide bond formation is determined by steps involving both conformational changes in the protein and intramolecular thiol :disulphide interchange.
Most of the model studies of protein disulphide bond formation have not been concerned with optimizing the rate of the process, and the regain of native state has occupied periods up to several hours. However, even in cases where the rate has been optimized by the use of high pH and nonphysiological additives, the half-times have been in the region of 10-30min. This is relevant to the consideration of the process in vivo.
The timing of disulphide bond formation during protein biosynthesis can be established by isolating nascent and newly synthesized radiolabelled polypeptides from a cell, tissue or translational system in oitro, by using a thiolblocking reagent such as iodoacetamide or N-ethylmaleimide in the homogenizing medium to prevent thiol oxidation or thiol : disulphide exchange during work up. This approach has established that intramolecular disulphide bonds in immunoglobulin light chains are formed cotranslationally, as are intermolecular disulphide bonds between nascent heavy chains and completed light or heavy chains. (Bergman & Kuehl, 1979a,b) . In nascent proalbumin chains, an average of 57% of the cysteine residues are disulphide bonded; 11 of the 17 intramolecular disulphide bonds are formed during translation and the remainder form within 30s (Peters & Davidson, 1982) . In procollagen, where the interchain disulphides are in Cterminal domains, the formation of these disulphides occurs shortly after completion and release of the chains (Oohira et al., 1979; Bruckner et al., 1981). The current data from all these systems are consistent with a model in which disulphide formation occurs rapidly after the appearance, within the lumen of the endoplasmic reticulum, of the complete domain of which the disulphide is to form part.
The contrast between the slow formation of native disulphide bonds in systems in vitro, and its rapid occurrence during biosynthesis, suggests that the process is enzyme-catalysed, and an enzyme capable of catalysing protein disulphide bond formation was sought and discovered 20 years ago (Goldberger ef al., 1963). The enzyme was initially shown to catalyse the air oxidation of reduced proteins, but it was subsequently found that this process involved chemical oxidation to form non-native disulphide-linked ('scrambled') products followed by enzyme-catalysed isomerization of the disulphide bonds (Givol et al., 1964) . The enzyme is therefore a catalyst of disulphide isomerization and is named protein disulphide-isomerase (PDI ; EC 5.3.4.1). It can be assayed by its ability to reactivate 'scrambled' ribonuclease. The enzyme was first purified and partially characterized by Anfinsen's group, who established its wide distribution, its broad specificity for protein substrates and its location in the microsomal fraction of liver homogenates (Anfinsen, 1972 (Anfinsen, , 1973 .
These properties are consistent with the enzyme playing a role in disulphide bond formation during protein biosynthesis, but they do not establish such a role. Anfinsen's work on PDI was published from 1963 to 1967 and little work on the enzyme appeared during the subsequent decade. However, there has been a revival of interest in recent years and new
